MOH Molina Healthcare Inc Common Stock
NYSE · Health Care · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Lug 23, 2026MOH Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
MOH Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 23 Maggio 2011 | 3-for-2 | Avanti |
Informazioni su Molina Healthcare Inc Common Stock Panoramica della società da Wikipedia
Molina Healthcare, Inc. is an American managed care company headquartered in Long Beach, California. The company provides health insurance to individuals through government programs such as Medicaid and Medicare.
History
Molina Healthcare was founded in 1980 by C. David Molina, an emergency room physician in Long Beach, California. He had seen an influx of patients using the emergency room for common illnesses such as a sore throat or the flu because they were being turned away by doctors who would not accept Medi-Cal. Molina established his first primary care clinic with the goal of treating the lowest-income patients, regardless of their ability to pay.
Leadership
For twenty years, the company was run by Dr. Molina's son, J. Mario Molina, MD, a physician. He was the president and CEO of the company. John Molina, Mario's younger brother, was the CFO of Molina Healthcare. The two took over Molina's operations after their father died in 1996 and continued to expand the company. In May 2017 Dr. J. Mario Molina and John Molina were removed from their positions by the Board of Directors, who cited poor financial performance as the reason for the change in leadership. Though the board also discused their displeasure in the CEO and CFO criticising President Donald Trump.[3][4] In October 2017 the company announced Joseph Zubretsky, the former CFO of Aetna, as Molina Healthcare's president and CEO.
Clinics
The first Molina Medical clinic was opened in Wilmington, California in 1980. The company formerly operated clinics in Washington, New Mexico, Florida and Utah. The clinics were opened to provide health care to low-income families and individuals. In August 2017 Molina Healthcare announced it would close several clinics in Michigan, Florida, New Mexico, Wisconsin, and Utah.
Becoming HMO
Molina Healthcare has focused on government-paid healthcare programs such as SCHIP and Medicaid since it became a health maintenance organization in 1985. From 1985 to 1997, the company was based solely in California.
Expansion of health plans
1997: Molina Healthcare acquires Health Reach Family Health Care and enters the states of Utah and Michigan.
2000: Molina Healthcare enters the state of Washington.
2004: Molina Healthcare enters the state of New Mexico.
2005: Molina Healthcare becomes a health plan in Ohio.
2006: Molina Healthcare enters the state of Texas.
2007: Molina Healthcare enters Missouri.
2008: Molina Healthcare enters Florida.
2010: Molina Healthcare enters Wisconsin.
2012: Molina Healthcare enters Illinois.
2013: Molina Healthcare enters South Carolina by acquiring assets from Community Health Solutions.
2013: Molina Healthcare acquires New Mexico Lovelace Medicaid contract.
2014: Molina Healthcare acquires Florida Medicaid assets from First Coast Advantage.
2015: Molina Healthcare enters Chicago market, acquiring MyCare Chicago's Medicaid assets.
2015: Molina Healthcare enters Puerto Rico.
2015: Molina Healthcare of Washington is the first health care company in the state to cover "Virtual Urgent Care" services.
2015: Molina Healthcare acquires Medicaid assets of Integral Health Plan, Inc. in Florida.
2015: Molina Healthcare acquires Providence Human Services and Community Services from Providence Service Corporation and renames them Pathways.
2015: Molina Healthcare adds online access to behavioral health.
2015: Molina Healthcare acquires HealthPlus MIChild and Medicaid programs of Michigan.
2015: Molina Healthcare acquires assets of Loyola Physician Partners' Medicaid Program of Illinois.
2017: Molina Healthcare exits the individual Marketplace in Utah and Wisconsin.
2018: Molina Healthcare loses Medicaid contract with the state of New Mexico.
2018: Molina Healthcare sells Pathways to Altar Capital
2019: Molina Healthcare loses Medicaid contract with the state of Texas.
2020: Molina Healthcare acquires Passport Health Plan in Kentucky.
2021: Molina Healthcare acquires Magellan Complete Care line of business from Magellan Health, Inc. With this acquisition, Molina enters Arizona, Massachusetts, and Virginia.
2021: Molina Healthcare acquires Affinity Health Plan in New York.
2021: Molina Healthcare acquires Cigna's Medicaid contracts in Texas.
2023: Molina Healthcare enters Iowa.
2023: Molina Healthcare loses Medicad contract with the state of Indiana.
2024: Molina Healthcare loses Medicaid contracts with the states of Virginia and Florida.
Going public
Molina Healthcare filed with the Securities and Exchange Commission for an initial stock offering in December 2002 and went public in July 2003 with a stock offering of $102 million. The shares were priced at $17.50, and Molina raised approximately $124 million in the initial public offering. In its stock market debut, Molina sold 6.6 million shares at $20.30, making the company the third-best first day gainer of 2003. Molina Healthcare was the first company from Inc. Magazine's "Inner City 100" list to go public.
Entering the Medicare market
Molina Healthcare entered the Medicare market in 2006. The company currently offers Medicare health plan options in: Arizona, California, Florida, Idaho, Illinois, Kentucky, Massachusetts, Michigan, Nevada, New Mexico, New York, Ohio, South Carolina, Texas, Utah, Virginia, Washington and Wisconsin.
Entering MMIS market
Molina Healthcare acquired Unisys' health information management business in December 2010 to create Molina Medicaid Solutions (MMS). MMS has Medicaid Management Information Systems (MMIS) contracts with Idaho, Louisiana, Maine, New Jersey, West Virginia and the U.S. Virgin Islands. In Autumn 2018, Molina Healthcare, Inc. sold its Medicaid management information systems business, Molina Medicaid Solutions (MMS), to DXC Technology. MMS was a wholly owned subsidiary of Molina Healthcare at the time of sale.
Entering health insurance marketplace
In 2014, Molina Healthcare began offering Marketplace plans in nine states where it offered Medicaid health plans through State Facilitated Marketplaces and Federally Facilitated Marketplace. On November 16, 2016 the Seattle Times reported that about 11 million people currently get their coverage through the exchange. In August 2017 Molina announced it would stop offering plans on the health insurance marketplaces in Utah, Wisconsin, and Maine in 2018.
Dual eligible demonstration projects
Molina was selected to participate in dual eligible demonstration projects in California, Ohio, Illinois, Michigan, South Carolina and Texas to serve patients who are eligible for both Medicare and Medicaid.
Criticism and controversies
A 2023 report investigating "High Rates of Prior
Authorization Denials" reported that Molina Healthcare's Medicaid plans for financially vulnerable people had some of the highest denial percentages in the country. It was reported, that Molina Healthcare operated plans that denied medical care under requests for prior authorization of services in more than 25% of cases in 2019. About 2.7 million people were enrolled in these plans at the time, while another 8.4 million people were enrolled in plans with denial rates higher than average at 15-25%. Some plans had even higher denial rates, as their Illinois plan 41% of requests.
Philanthropy
In May 2022, MolinaCares presented a $100,000 grant to support Compass Health's Broadway Campus Redevelopment Project. The grant will aid funding of construction of a 72,000 square-foot, state-of-the-art facility that will expand community-based behavioural health care services and its workforce in northwest Washington.
In August 2026, MolinaCares awarded a grant of $150,000 to literacy non-profit Indy Reads, to launch a new program in health literacy, in partnership with Molina Healthcare.
Awards and recognition
Molina Healthcare was awarded the 2011 Alfred P. Sloan Award for Business Excellence in Workplace Flexibility. The award ranked Molina Healthcare in the top 20 percent of employers nationally in terms of its programs, policies and culture for creating an effective and flexible workplace. In 2006, Molina Healthcare was named among the 100 best corporate citizens by Business Ethics magazine. In 2005, Time magazine recognized Dr. J. Mario Molina, then CEO of Molina Healthcare, as one of the 25 most influential Hispanics in America.
The company ranked 155th on the 2021 Fortune 500 list of the largest United States corporations by revenue. The company ranked 126th on the 2023 Fortune 500 list of the largest United States corporations by revenue.
Other awards and recognition
2014: Milwaukee Journal Sentinel Recognizes Molina Healthcare of Wisconsin with a Top Workplace Award 2014
2014: Molina Healthcare of New Mexico voted Best Places to Work by Albuquerque Business First
2014: Molina Healthcare was one of 26 companies to participate in President Obama's SupplierPay 2014
2015: Molina Healthcare voted Top Ten Least Stressful Companies to Work for In America 2015
2015: Molina Healthcare ranked 301 in top Fortune 500 2015
2016: Molina Healthcare ranked 201 in top Fortune 500 2016
2017: Molina Healthcare ranked 156 in Fortune 500 2017
2023: Molina Healthcare of Kentucky awarded One of Kentucky's Best Places to Work
2023: Molina Healthcare recognized as one of America's Best-in-State Employers by Forbes
2023: Molina Healthcare recognized as one of Time's World's Best Companies of 2023
2023: Molina Healthcare recognized as one of Newsweek's Greatest Workplaces for Parents and Families 2023
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | MOH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | 1053.0media 5 anni ≈21.1 | ≈21.1 | 36.3 | Sopravvalutato | |
| P/S (TTM) | 0.2media 5 anni ≈0.5 | ≈0.5 | 0.7 | Sottovalutato | |
| P/B (MRQ) | 2.4media 5 anni ≈4.3 | ≈4.3 | 3.9 | Sottovalutato | |
| EV / EBITDA (TTM) | 12.7media 5 anni ≈7.0 | ≈7.0 | 16.1 | Sottovalutato | |
| Prezzo / FCF (TTM) | 36.4media 5 anni ≈14.4 | ≈14.4 | · | · | |
| Prezzo / Flusso di cassa (TTM) | 27.0media 5 anni ≈11.5 | ≈11.5 | · | · | |
| EV / Ricavi (TTM) | 0.1media 5 anni ≈0.3 | ≈0.3 | · | · | |
| EV / FCF (TTM) | 17.4media 5 anni ≈10.3 | ≈10.3 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 5.3media 5 anni ≈7.7 | ≈7.7 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | MOH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine Operativo (TTM) | 0.46%media 5 anni ≈3.6% | ≈3.6% | 3.5% | Debole | |
| Margine EBITDA (TTM) | 0.83%media 5 anni ≈4.1% | ≈4.1% | 3.7% | Debole | |
| Margine ante imposte (TTM) | -0.01%media 5 anni ≈3.2% | ≈3.2% | 2.8% | Debole | |
| Margine di Profitto Netto (TTM) | -0.02%media 5 anni ≈2.4% | ≈2.4% | 2.9% | Debole | |
| ROA (TTM) | -0.04%media 5 anni ≈6.3% | ≈6.3% | 3.0% | In linea | |
| ROE (TTM) | -0.16%media 5 anni ≈23.1% | ≈23.1% | 10.1% | In linea | |
| ROIC | 8.0%media 5 anni ≈15.3% | ≈15.3% | 8.0% | In linea |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | MOH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | 0.9media 5 anni ≈0.7 | ≈0.7 | 0.7 | Debito elevato | |
| Rapporto corrente (MRQ) | 1.7media 5 anni ≈1.5 | ≈1.5 | 1.7 | In linea | |
| Quick Ratio (MRQ) | 1.6media 5 anni ≈1.5 | ≈1.5 | 1.3 | Liquidità elevata | |
| Debito a lungo termine / Patrimonio netto (MRQ) | 0.9media 5 anni ≈0.7 | ≈0.7 | 0.7 | Debito elevato |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | MOH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 11.8%media 5 anni ≈19.1% | ≈19.1% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 12.4%media 5 anni ≈15.5% | ≈15.5% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 18.5% | · | · | · | |
| EPS YoY | -56.3%media 5 anni ≈2.3% | ≈2.3% | · | · | |
| Net Income YoY (Utile Netto YoY) | -60.0%media 5 anni ≈0.79% | ≈0.79% | · | · | |
| EPS CAGR 3Y (CAGR EPS 3 anni) | -13.0%media 5 anni ≈9.2% | ≈9.2% | · | · | |
| EPS CAGR 5Y (CAGR EPS 5 anni) | -4.5% | · | · | · | |
| Net Income CAGR 3Y (CAGR Utile Netto 3 anni) | -15.8%media 5 anni ≈7.7% | ≈7.7% | · | · | |
| Net Income CAGR 5Y (CAGR Utile Netto 5 anni) | -6.9% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | MOH | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 2.9media 5 anni ≈2.6 | ≈2.6 | 2.4 | Di prim'ordine | |
| Receivables Turnover (Rotazione dei crediti) | 13.3media 5 anni ≈13.5 | ≈13.5 | 16.3 | Sotto la media | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$2.4M | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Lug 21, 2026 | $1.51 | $1.40 | 7.5% |
| 31 Marzo 2026 | $2.35 | $1.94 | 21.0% | |
| 31 Dicembre 2025 | $-2.75 | $0.34 | -916.0% | |
| 30 Settembre 2025 | $1.84 | $3.94 | -53.3% | |
| 30 Giugno 2025 | $5.48 | $5.85 | -6.3% | |
| 31 Marzo 2025 | $6.08 | $6.02 | 1.1% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Cost of Revenue | $39.49B | $34.43B | $28.67B | $27.18B | $23.70B | $15.82B | $13.90B | · | · | · | · | · | |
| Gross Profit | · | · | · | · | · | $2.48B | $2.30B | $2.52B | $1.81B | $1.73B | $1.53B | $1.00B | |
| SG&A Expense | $3.01B | $2.74B | $2.46B | $2.31B | $2.07B | $1.48B | $1.30B | $1.33B | $1.59B | $1.39B | $1.15B | $765M | |
| Operating Expenses | $44.65B | $38.94B | $32.50B | $30.80B | $26.75B | $18.34B | $15.79B | $17.76B | $20.44B | $17.48B | $13.79B | $9.47B | |
| Operating Income | $781M | $1.71B | $1.57B | $1.17B | $1.02B | $1.08B | $1.04B | $1.13B | $-555M | $306M | $387M | $193M | |
| Interest Expense | · | · | $109M | $110M | $120M | $102M | $87M | $115M | $118M | $101M | $66M | $57M | |
| Interest Income | · | · | · | $75M | $77M | $17M | $17M | $125M | $70M | $38M | $23M | $20M | |
| Other Non-op | · | · | $0 | $0 | $-25M | $-15M | $15M | $-17M | $61M | $0 | $1M | $-1M | |
| Pretax Income | $589M | $1.59B | $1.46B | $1.06B | $875M | $961M | $972M | $999M | $-612M | $205M | $322M | $135M | |
| Income Tax | $117M | $410M | $373M | $271M | $216M | $288M | $235M | $292M | $-100M | $153M | $179M | $73M | |
| Net Income | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| EPS (Basic) | $8.93 | $20.52 | $18.91 | $13.72 | $11.40 | $11.40 | $11.85 | $11.57 | $-9.07 | $0.93 | $2.75 | $1.33 | |
| EPS (Diluted) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 | |
| Shares (Basic) | 52,800,000 | 57,400,000 | 57,700,000 | 57,800,000 | 57,800,000 | 59,000,000 | 62,200,000 | 61,000,000 | 56,000,000 | 55,400,000 | 52,000,000 | 47,000,000 | |
| Shares (Diluted) | 52,900,000 | 57,700,000 | 58,100,000 | 58,500,000 | 58,600,000 | 59,900,000 | 64,200,000 | 67,000,000 | 56,000,000 | 56,000,000 | 56,000,000 | 48,000,000 | |
| EBITDA | $976M | $1.89B | $1.74B | $1.35B | $1.15B | $1.17B | $1.13B | $1.26B | $-377M | $488M | $513M | $327M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.25B | $4.66B | $4.85B | $4.01B | $4.44B | $4.15B | $2.45B | $2.83B | $3.19B | $2.82B | $2.33B | $1.54B | |
| Short-term Investments | $4.01B | $4.33B | $4.26B | $3.50B | $3.20B | $1.88B | $1.95B | $1.68B | $2.52B | $1.76B | $1.80B | $1.02B | |
| Receivables | $3.53B | $3.30B | $3.10B | $2.30B | $2.18B | $1.67B | $1.41B | $1.33B | $871M | $974M | $597M | $596M | |
| Prepaid Expense | $655M | $487M | $331M | $277M | $247M | $175M | $163M | $149M | $239M | $131M | $192M | $49M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $51M | |
| Current Assets | $12.44B | $12.77B | $12.54B | $10.08B | $10.06B | $7.88B | $5.97B | $6.46B | $7.51B | $5.99B | $5.31B | $3.20B | |
| PP&E (Net) | · | · | · | · | · | · | · | $241M | $342M | $454M | $393M | $341M | |
| PP&E (Gross) | $1.11B | $1.03B | $932M | $882M | $822M | $752M | $687M | $774M | $883M | $919M | $755M | $618M | |
| Accum. Depreciation | $875M | $806M | $729M | $695M | $632M | $577M | $530M | $533M | $541M | $465M | $362M | $277M | |
| Goodwill | $1.96B | $1.67B | $1.24B | $1.11B | $982M | $692M | $143M | $143M | $186M | $620M | $519M | $272M | |
| Intangibles | $237M | $267M | $208M | $275M | $270M | $249M | $29M | $47M | $69M | $140M | $122M | $89M | |
| Other Non-current Assets | $147M | $138M | $143M | $123M | $179M | $119M | $105M | $24M | $141M | $41M | $28M | $30M | |
| Total Assets | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Accounts Payable | $1.09B | $1.33B | $1.25B | $889M | $842M | $641M | $502M | $390M | $366M | $385M | $362M | $242M | |
| Current Liabilities | $7.37B | $7.90B | $8.17B | $6.86B | $7.05B | $4.96B | $3.27B | $4.25B | $5.56B | $4.57B | $3.82B | $2.17B | |
| Capital Leases | $56M | $68M | $85M | $77M | $99M | $42M | $48M | $197M | $198M | $198M | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $0 | $15M | $0 | $24M | |
| Other Non-current Liabilities | $173M | $120M | $124M | $104M | $140M | $119M | $90M | $44M | $61M | $42M | $37M | $34M | |
| Total Liabilities | $11.49B | $11.13B | $10.68B | $9.35B | $9.58B | $7.44B | $4.83B | $5.51B | $7.13B | $5.80B | $5.02B | $3.42B | |
| Long-term Debt | · | · | · | · | · | $2.13B | $1.25B | · | · | $1.65B | $1.41B | $690M | |
| Total Debt | $3.77B | $2.92B | $2.18B | $2.18B | $2.17B | $2.13B | $1.24B | $1.02B | $1.32B | $1.65B | $449M | $341.0K | |
| Retained Earnings | $3.60B | $4.09B | $3.89B | $2.80B | $2.40B | $1.86B | $1.78B | $1.01B | $298M | $810M | $758M | $615M | |
| AOCI | $15M | $-57M | $-82M | $-160M | $-5M | $37M | $4M | $-8M | $-5M | $-2M | $-4M | $-1M | |
| Stockholders' Equity | $4.07B | $4.50B | $4.21B | $2.96B | $2.63B | $2.10B | $1.96B | $1.65B | $1.34B | $1.65B | $1.56B | $1.01B | |
| Liabilities + Equity | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Shares Outstanding | 51,000,000 | 56,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 59,000,000 | 62,000,000 | 62,000,000 | 60,000,000 | 57,000,000 | 56,000,000 | 50,000,000 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $195M | $186M | $171M | $176M | $131M | $88M | $89M | $127M | $178M | $182M | $126M | $134M | |
| Stock-based Comp | $47M | $116M | $115M | $103M | $72M | $57M | $39M | $27M | $46M | $26M | $23M | $22M | |
| Deferred Tax | $43M | $53M | $-31M | $-66M | $-24M | $-19M | $10M | $-6M | $-94M | $22M | $-7M | $-2M | |
| Amort. of Intangibles | $91M | $82M | $85M | $77M | $49M | $15M | $18M | $21M | $31M | $32M | $17M | $18M | |
| Restructuring | · | · | · | · | · | · | · | $8M | $150M | · | · | · | |
| Other Non-cash | $-1.29B | $-890M | $316M | $-232M | $1.28B | $1.09B | $-448M | $-1.17B | $1.19B | $391M | $840M | $844M | |
| Operating Cash Flow | $-535M | $644M | $1.66B | $773M | $2.12B | $1.90B | $434M | $-314M | $804M | $673M | $1.12B | $1.06B | |
| CapEx | $101M | $100M | $84M | $91M | $77M | $74M | $57M | $30M | $86M | $176M | $132M | $115M | |
| Investing Cash Flow | $312M | $-464M | $-744M | $-790M | $-1.65B | $-400M | $-293M | $1.14B | $-1.06B | $-206M | $-1.42B | $-536M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $373M | $0 | |
| Stock Repurchased | $1.00B | $1.00B | $0 | $400M | $128M | $606M | $47M | $0 | $0 | · | $0 | $0 | |
| Net Stock Activity | $-1.00B | $-1.00B | $0 | $-400M | $-128M | $-606M | $-47M | · | $0 | $0 | $373M | $0 | |
| Financing Cash Flow | $-170M | $-347M | $-58M | $-441M | $-183M | $217M | $-559M | $-1.19B | $636M | $19M | $1.08B | $79M | |
| Net Change in Cash | $-393M | $-167M | $860M | $-458M | $283M | $1.72B | $-418M | $-364M | $378M | $486M | $790M | $603M | |
| Taxes Paid | $275M | $379M | $405M | $340M | $235M | $321M | $239M | $240M | $7M | $153M | $197M | $30M | |
| Free Cash Flow | $-636M | $544M | $1.58B | $682M | $2.04B | $1.82B | $370M | $-344M | $718M | $497M | · | · | |
| Levered FCF | · | · | $1.50B | $600M | $1.95B | $1.74B | $304M | $-425M | $619M | $471M | · | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 12.8% | 13.7% | 13.3% | 9.1% | 9.4% | 10.6% | · | |
| Operating Margin | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% | 5.5% | 6.2% | 6.0% | -2.8% | 1.7% | 2.7% | 2.0% | |
| Net Margin | 1.0% | 2.9% | 3.2% | 2.5% | 2.4% | 3.5% | 4.4% | 3.7% | -2.6% | 0.29% | 1.0% | 0.64% | |
| Pretax Margin | 1.3% | 3.9% | 4.3% | 3.3% | 3.1% | 5.0% | 5.8% | 5.3% | -3.1% | 1.1% | 2.3% | 1.4% | |
| EBITDA Margin | 2.1% | 4.7% | 5.1% | 4.2% | 4.1% | 6.0% | 6.7% | 6.7% | -1.9% | 2.7% | 3.6% | 3.4% | |
| ROA | 3.0% | 7.7% | 8.0% | 6.5% | 6.1% | 8.2% | 10.6% | 9.0% | -6.4% | 0.74% | 2.6% | 1.7% | |
| ROE | 10.9% | 25.4% | 27.0% | 26.4% | 25.6% | 33.2% | 40.9% | 47.4% | -34.3% | 3.2% | 11.1% | 6.5% | |
| ROIC | 8.0% | 17.1% | 18.3% | 17.0% | 16.0% | 17.9% | 24.8% | 30.0% | -17.5% | 2.4% | 8.6% | 8.8% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 | 1.6 | 1.8 | 1.5 | 1.4 | 1.3 | 1.4 | 1.5 | |
| Quick Ratio | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 | 1.6 | 1.8 | 1.4 | 1.2 | 1.2 | 1.2 | 1.5 | |
| Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 1.0 | 0.3 | 0.0 | |
| LT Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 0.7 | · | · | |
| Interest Coverage | · | · | 14.4 | 10.7 | 8.5 | 10.6 | 12.0 | 9.8 | -4.7 | 3.0 | 5.9 | 3.4 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.9 | 2.7 | 2.5 | 2.6 | 2.6 | 2.4 | 2.4 | 2.4 | 2.5 | 2.5 | 2.6 | 2.6 | |
| Receivables Turnover | 13.3 | 12.7 | 12.6 | 14.3 | 14.4 | 12.6 | 12.3 | 17.2 | 21.6 | 22.6 | 23.8 | 21.6 |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $79.78 | $80.29 | $72.67 | $51.10 | · | $35.53 | $31.61 | $26.56 | $22.28 | $28.93 | $27.80 | $20.32 | |
| Revenue / Share | $858.71 | $704.51 | $586.44 | $546.56 | $473.91 | $323.72 | $262.95 | $283.63 | $355.05 | $317.54 | $253.18 | $199.97 | |
| Cash Flow / Share | $-10.11 | $11.16 | $28.61 | $13.21 | $36.16 | $31.50 | $6.67 | $-4.71 | $14.36 | $12.02 | $20.09 | $21.93 | |
| Cash / Share | $83.29 | $83.25 | $83.59 | $69.07 | · | $70.41 | $39.55 | $45.58 | $53.10 | $49.46 | $41.59 | $30.95 | |
| EPS (TTM) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 19.3% | 6.6% | 15.1% | 43.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.4% | 13.5% | 20.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -56.3% | 8.8% | 38.5% | 20.4% | 0.18% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -13.0% | 22.0% | 18.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -4.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -60.0% | 8.1% | 37.8% | 20.2% | -2.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.8% | 21.4% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.9% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Net Income TTM | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| Market Cap | $8.85B | $16.30B | $20.96B | $19.15B | · | $12.55B | $8.41B | $7.21B | $4.60B | $3.09B | $3.37B | $2.66B | |
| Enterprise Value | $4.36B | $10.23B | $14.03B | $13.82B | · | $8.65B | $5.25B | $3.72B | $209M | $161M | $-314M | $104M | |
| P/E | 19.5 | 14.3 | 19.2 | 24.4 | 28.3 | 18.9 | 11.8 | 11.0 | -8.5 | 59.0 | 23.3 | 41.5 | |
| P/S | 0.2 | 0.4 | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | |
| P/B | 2.2 | 3.6 | 5.0 | 6.5 | · | 6.0 | 4.3 | 4.4 | 3.4 | 1.9 | 2.2 | 2.6 | |
| P / Tangible Book | 4.7 | 6.4 | 7.6 | 12.2 | · | 10.9 | · | · | · | · | · | · | |
| P / Cash Flow | -16.5 | 25.3 | 12.6 | 24.8 | · | 6.6 | 19.7 | -22.9 | 5.7 | 4.6 | 3.0 | 2.5 | |
| P / FCF | -13.9 | 30.0 | 13.3 | 28.1 | · | 6.9 | 22.7 | -20.9 | 6.4 | 6.2 | · | · | |
| EV / EBITDA | 4.5 | 5.4 | 8.0 | 10.2 | · | 7.4 | 4.6 | 3.0 | -0.6 | 0.3 | -0.6 | 0.3 | |
| EV / FCF | -6.9 | 18.8 | 8.9 | 20.3 | · | 4.8 | 14.2 | -10.8 | 0.3 | 0.3 | · | · | |
| EV / Revenue | 0.1 | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.2 | 0.0 | 0.0 | -0.0 | 0.0 | |
| Earnings Yield | 5.1% | 7.0% | 5.2% | 4.1% | 3.5% | 5.3% | 8.5% | 9.1% | -11.8% | 1.7% | 4.3% | 2.4% |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.87B | $10.80B | $11.38B | $11.48B | $11.43B | $11.15B | $10.50B | $10.34B | $9.88B | $9.93B | $9.05B | $8.55B | $8.33B | $8.15B | $8.22B | $7.93B | |
| Cost of Revenue | $9.44B | $9.27B | $10.14B | $10.04B | $9.83B | $9.48B | $9.00B | $8.64B | $8.37B | $8.41B | $7.45B | $7.31B | $7.04B | $6.87B | $6.99B | $6.75B | |
| SG&A Expense | $724M | $779M | $795M | $729M | $711M | $774M | $665M | $676M | $691M | $711M | $645M | $608M | $618M | $591M | $629M | $560M | |
| Operating Expenses | $10.73B | $10.71B | $11.54B | $11.34B | $11.05B | $10.71B | $10.12B | $9.87B | $9.45B | $9.51B | $8.73B | $8.19B | $7.88B | $7.69B | $8.12B | $7.59B | |
| Operating Income | $145M | $83M | $-162M | $137M | $373M | $433M | $380M | $467M | $434M | $426M | $316M | $359M | $443M | $455M | $105M | $335M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $27M | · | $27M | $27M | $28M | · | $28M | |
| Interest Income | · | · | · | · | · | · | · | $20M | $21M | $22M | · | $20M | $19M | $21M | · | $19M | |
| Other Non-op | · | · | · | · | · | · | · | · | $-28M | $-27M | · | $-27M | $-27M | $-28M | · | $-28M | |
| Pretax Income | $91M | $29M | $-214M | $88M | $325M | $390M | $346M | $438M | $406M | $399M | $289M | $332M | $416M | $427M | $78M | $307M | |
| Income Tax | $31M | $15M | $-54M | $9M | $70M | $92M | $95M | $112M | $105M | $98M | $73M | $87M | $107M | $106M | $22M | $77M | |
| Net Income | $60M | $14M | $-160M | $79M | $255M | $298M | $251M | $326M | $301M | $301M | $216M | $245M | $309M | $321M | $56M | $230M | |
| EPS (Basic) | $1.19 | $0.27 | $-2.80 | $1.51 | $4.75 | $5.47 | $4.46 | $5.67 | $5.18 | $5.21 | $3.72 | $4.24 | $5.37 | $5.58 | $0.98 | $4.00 | |
| EPS (Diluted) | $1.19 | $0.27 | $-2.79 | $1.51 | $4.75 | $5.45 | $4.43 | $5.65 | $5.17 | $5.17 | $3.69 | $4.21 | $5.35 | $5.52 | $0.96 | $3.95 | |
| Shares (Basic) | 51,100,000 | 50,900,000 | · | 52,500,000 | 53,600,000 | 54,600,000 | · | 57,600,000 | 58,100,000 | 57,900,000 | · | 57,800,000 | 57,700,000 | 57,500,000 | · | 57,600,000 | |
| Shares (Diluted) | 51,300,000 | 51,000,000 | · | 52,500,000 | 53,700,000 | 54,800,000 | · | 57,700,000 | 58,200,000 | 58,300,000 | · | 58,100,000 | 57,900,000 | 58,000,000 | · | 58,300,000 | |
| EBITDA | $145M | $122M | · | $137M | $373M | $481M | · | $467M | $434M | $471M | · | $359M | $443M | $499M | · | $335M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.99B | $5.31B | $4.25B | $4.22B | $4.50B | $4.86B | $4.66B | $4.73B | $4.35B | $4.51B | $4.85B | $5.57B | $4.91B | $4.55B | $4.01B | $4.24B | |
| Short-term Investments | $3.93B | $3.94B | $4.01B | $4.23B | $4.31B | $4.44B | $4.33B | $4.48B | $4.35B | $4.42B | · | $4.11B | $3.89B | $3.81B | · | $3.64B | |
| Receivables | $3.48B | $3.42B | $3.53B | $3.52B | $3.87B | $3.49B | $3.30B | $3.26B | $3.23B | $3.35B | · | $2.46B | $2.38B | $2.54B | · | $2.22B | |
| Prepaid Expense | $528M | $655M | $655M | $590M | $438M | $472M | $487M | $408M | $399M | $381M | · | $332M | $260M | $259M | · | $391M | |
| Current Assets | $12.93B | $13.33B | $12.44B | $12.55B | $13.11B | $13.26B | $12.77B | $12.88B | $12.33B | $12.67B | · | $12.47B | $11.44B | $11.16B | · | $10.49B | |
| PP&E (Gross) | · | · | $1.11B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $875M | · | · | · | $806M | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | $1.96B | · | · | · | $1.67B | · | · | · | $1.24B | · | · | · | $1.11B | · | |
| Intangibles | · | · | $237M | · | · | · | $267M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $140M | $146M | $147M | $142M | $148M | $163M | $138M | $132M | $136M | $134M | · | $125M | $118M | $119M | · | $186M | |
| Total Assets | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Accounts Payable | $1.14B | $1.16B | $1.09B | $1.12B | $1.11B | $1.12B | $1.33B | $1.22B | $973M | $1.11B | · | $1.09B | $857M | $787M | · | $818M | |
| Current Liabilities | $7.70B | $8.19B | $7.37B | $7.48B | $7.88B | $8.15B | $7.90B | $8.34B | $7.84B | $8.51B | · | $8.49B | $7.54B | $7.61B | · | $7.24B | |
| Capital Leases | · | · | $56M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $179M | $176M | $173M | $174M | $167M | $155M | $120M | $122M | $122M | $124M | · | $121M | $122M | $88M | · | $118M | |
| Total Liabilities | $11.83B | $12.31B | $11.49B | $11.51B | $11.61B | $12.08B | $11.13B | $10.99B | $10.34B | $11.02B | · | $10.99B | $10.04B | $10.08B | · | $9.75B | |
| Total Debt | $3.77B | $3.77B | · | $3.66B | $3.38B | $3.57B | · | $2.33B | $2.18B | $2.18B | · | $2.18B | $2.18B | $2.18B | · | $2.17B | |
| Retained Earnings | $3.68B | $3.62B | $3.60B | $3.76B | $4.16B | $3.90B | $4.09B | $4.33B | $4.49B | $4.19B | · | $3.67B | $3.43B | $3.12B | · | $2.94B | |
| AOCI | $-16M | $-7M | $15M | $9M | $-10M | $-28M | $-57M | $-9M | $-85M | $-85M | · | $-165M | $-146M | $-125M | · | $-185M | |
| Stockholders' Equity | $4.17B | $4.08B | $4.07B | $4.19B | $4.60B | $4.31B | $4.50B | $4.77B | $4.84B | $4.49B | $4.21B | $3.88B | $3.62B | $3.29B | $2.96B | $3.04B | |
| Liabilities + Equity | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Shares Outstanding | 52,000,000 | 52,000,000 | 51,000,000 | 51,000,000 | 54,000,000 | 54,000,000 | 56,000,000 | 57,000,000 | 59,000,000 | 59,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40M | $39M | $44M | $45M | $58M | $48M | $48M | $47M | $46M | $45M | $43M | $42M | $42M | $44M | $47M | $45M | |
| Stock-based Comp | $26M | $33M | $20M | $-3M | $3M | $27M | $18M | $30M | $32M | $36M | $27M | $33M | $30M | $25M | $23M | $23M | |
| Other Non-cash | · | $996M | · | · | · | $-183M | · | · | · | $-168M | · | · | · | $526M | · | · | |
| Operating Cash Flow | $-294M | $1.08B | $-298M | $-125M | $-302M | $190M | $-224M | $873M | $-219M | $214M | $-690M | $949M | $487M | $916M | $-212M | $254M | |
| CapEx | $30M | $27M | $-1M | $38M | $42M | $22M | $11M | $35M | $27M | $27M | $-5M | $26M | $31M | $32M | $10M | $31M | |
| Investing Cash Flow | $-30M | $11M | $230M | $77M | $128M | $-123M | $19M | $-48M | $53M | $-488M | $-25M | $-280M | $-137M | $-302M | $148M | $-347M | |
| Stock Repurchased | $0 | $0 | $0 | $500M | $0 | $500M | $500M | $500M | $0 | $0 | $0 | $0 | · | · | $200M | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-500M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-4M | $-20M | $92M | $-220M | $-189M | $147M | $67M | $-364M | $12M | $-62M | $3M | $-6M | $10M | $-65M | $-183M | $10M | |
| Net Change in Cash | $-328M | $1.07B | $24M | $-268M | $-363M | $214M | $-138M | $461M | $-154M | $-336M | $-712M | $663M | $360M | $549M | $-247M | $-83M | |
| Free Cash Flow | · | $1.05B | · | · | · | $168M | · | · | · | $187M | · | · | · | $884M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $167M | · | · | · | $863M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 1.3% | 0.77% | · | 1.2% | 3.3% | 3.9% | · | 4.5% | 4.4% | 4.3% | · | 4.2% | 5.3% | 5.6% | · | 4.2% | |
| Net Margin | 0.55% | 0.13% | · | 0.69% | 2.2% | 2.7% | · | 3.1% | 3.0% | 3.0% | · | 2.9% | 3.7% | 3.9% | · | 2.9% | |
| Pretax Margin | 0.84% | 0.27% | · | 0.77% | 2.8% | 3.5% | · | 4.2% | 4.1% | 4.0% | · | 3.9% | 5.0% | 5.2% | · | 3.9% | |
| EBITDA Margin | 1.3% | 1.1% | · | 1.2% | 3.3% | 4.3% | · | 4.5% | 4.4% | 4.7% | · | 4.2% | 5.3% | 6.1% | · | 4.2% | |
| ROA | 0.37% | 0.09% | · | 0.50% | 1.6% | 1.9% | · | 2.1% | 2.1% | 2.1% | · | 1.8% | 2.4% | 2.5% | · | 1.9% | |
| ROE | 1.4% | 0.33% | · | 1.8% | 5.4% | 6.8% | · | 7.5% | 7.1% | 7.7% | · | 7.1% | 9.6% | 10.6% | · | 8.3% | |
| ROIC | 1.2% | 0.51% | · | 1.6% | 3.7% | 4.2% | · | 4.9% | 4.6% | 4.8% | · | 4.4% | 5.7% | 6.3% | · | 4.8% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.6 | · | 1.5 | 1.6 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.6 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 | |
| Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 15.8 | · | 13.3 | 16.4 | 16.2 | · | 12.0 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.6 | · | 0.7 | |
| Receivables Turnover | 3.0 | 3.1 | · | 3.4 | 3.2 | 3.3 | · | 3.6 | 3.5 | 3.4 | · | 3.7 | 3.6 | 3.5 | · | 3.8 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $80.21 | $78.46 | · | $82.18 | $85.24 | $79.81 | · | $83.68 | $82.08 | $76.15 | · | $66.88 | $62.43 | $56.69 | · | $52.43 | |
| Revenue / Share | $211.97 | $211.69 | · | $218.61 | $212.79 | $203.41 | · | $179.20 | $169.76 | $170.34 | · | $147.13 | $143.82 | $140.50 | · | $135.97 | |
| Cash Flow / Share | · | $21.22 | · | · | · | $3.47 | · | · | · | $3.67 | · | · | · | $15.79 | · | · | |
| Cash / Share | $95.87 | $102.19 | · | $82.76 | $83.31 | $89.93 | · | $83.02 | $73.80 | $76.49 | · | $95.95 | $84.66 | $78.52 | · | $73.14 | |
| EPS (TTM) | $0.18 | $3.74 | · | $16.14 | $20.28 | $20.70 | · | $19.68 | $18.24 | $18.42 | · | $16.04 | $15.78 | $14.68 | · | $14.33 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.52B | $45.08B | · | $44.55B | $43.41B | $41.87B | · | $39.20B | $37.41B | $35.85B | · | $33.25B | $32.63B | $32.35B | · | $31.16B | |
| Net Income TTM | $-7M | $188M | · | $883M | $1.13B | $1.18B | · | $1.14B | $1.06B | $1.07B | · | $931M | $916M | $855M | · | $839M | |
| Market Cap | $11.89B | $6.93B | · | $9.76B | $16.09B | $17.79B | · | $19.64B | $17.54B | $24.24B | · | $19.02B | $17.47B | $15.51B | · | $19.13B | |
| Enterprise Value | $6.75B | $1.45B | · | $4.98B | $10.65B | $12.07B | · | $12.76B | $11.02B | $17.48B | · | $11.52B | $10.85B | $9.33B | · | $13.42B | |
| P/E | 1270.6 | 35.6 | · | 11.9 | 14.7 | 15.9 | · | 17.5 | 16.3 | 22.3 | · | 20.4 | 19.1 | 18.2 | · | 23.0 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | |
| P/B | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Tangible Book | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Cash Flow | · | 6.4 | · | · | · | 93.6 | · | · | · | 113.3 | · | · | · | 16.9 | · | · | |
| EV / Revenue | 0.2 | 0.0 | · | 0.1 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| Earnings Yield | 0.08% | 2.8% | · | 8.4% | 6.8% | 6.3% | · | 5.7% | 6.1% | 4.5% | · | 4.9% | 5.2% | 5.5% | · | 4.3% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B |
| Margine Operativo % | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% |
| Utile netto | $472M | $1.18B | $1.09B | $792M | $659M |
| EPS Diluito | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 |
| Rapporto corrente | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 |
| Quick Ratio | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-636M | $544M | $1.58B | $682M | $2.04B |
Proprietari istituzionali (13F) 673 filer · $13.8B totale · Aggiornato al 30 Settembre 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 159 (+18 vs trimestre precedente) | 68 (-75 vs trimestre precedente) | 219 (+23 vs trimestre precedente) | 181 (+8 vs trimestre precedente) | +1.1M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $1.503.052.088 | 6.572.156 | 10,91% | Azioni |
| VANGUARD GROUP INC | $1.055.736.837 | 6.083.536 | 7,66% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $806.903.452 | 3.560.601 | 5,86% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $638.128.574 | 2.790.243 | 4,63% | Azioni |
| Capital World Investors | $586.138.203 | 2.562.913 | 4,26% | Azioni |
| Lingotto Investment Management LLP | $574.377.763 | 2.511.490 | 4,17% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $538.648.191 | 2.355.261 | 3,91% | Azioni |
| FMR LLC | $427.964.063 | 1.871.290 | 3,11% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $427.014.918 | 1.867.140 | 3,10% | Azioni |
| STATE STREET CORP | $401.475.303 | 1.755.467 | 2,91% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $318.659.985 | 1.393.338 | 2,31% | Azioni |
| GOLDMAN SACHS GROUP INC | $298.810.862 | 1.306.563 | 2,17% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $289.810.242 | 1.267.207 | 2,10% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $289.611.501 | 1.266.338 | 2,10% | Azioni |
| Capital Research Global Investors | $249.797.804 | 1.092.251 | 1,81% | Azioni |
| MORGAN STANLEY | $230.316.927 | 1.007.068 | 1,67% | Azioni |
| HARRIS ASSOCIATES L P | $218.980.250 | 957.500 | 1,59% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $204.005.369 | 891.772 | 1,48% | Azioni |
| 8 KNOTS MANAGEMENT, LLC | $198.942.438 | 1.146.378 | 1,44% | Azioni |
| MANNING & NAPIER ADVISORS LLC | $152.338.582 | 663.669 | 1,11% | Azioni |
| UBS Group AG | $142.749.967 | 624.180 | 1,04% | Azioni |
| Long Focus Capital Management, LLC | $139.507.000 | 610.000 | 1,01% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $131.512.792 | 575.045 | 0,95% | Azioni |
| TWO SIGMA ADVISERS, LP | $116.582.437 | 671.790 | 0,85% | Azioni |
| Invesco Ltd. | $116.332.600 | 508.669 | 0,84% | Azioni |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $115.548.617 | 505.241 | 0,84% | Azioni |
| NORTHERN TRUST CORP | $88.292.838 | 386.064 | 0,64% | Azioni |
| NORGES BANK | $87.054.426 | 380.649 | 0,63% | Azioni |
| Bank of New York Mellon Corp | $86.138.019 | 376.642 | 0,63% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $82.789.400 | 362.000 | 0,60% | Opzione Put |
| BNP PARIBAS FINANCIAL MARKETS | $82.559.556 | 360.995 | 0,60% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $75.497.758 | 330.117 | 0,55% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $72.051.935 | 315.050 | 0,52% | Azioni |
| BANK OF AMERICA CORP /DE/ | $71.479.956 | 312.549 | 0,52% | Azioni |
| Amundi | $59.944.786 | 262.111 | 0,44% | Azioni |
| PRINCIPAL FINANCIAL GROUP INC | $57.795.692 | 252.714 | 0,42% | Azioni |
| Maple Rock Capital Partners Inc. | $55.642.710 | 243.300 | 0,40% | Azioni |
| Russell Investments Group, Ltd. | $53.133.740 | 232.165 | 0,39% | Azioni |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | $52.660.005 | 230.258 | 0,38% | Azioni |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $51.238.863 | 224.044 | 0,37% | Azioni |
| D. E. Shaw & Co., Inc. | $47.575.775 | 208.027 | 0,35% | Azioni |
| CITIGROUP INC | $47.390.070 | 207.215 | 0,34% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46.357.490 | 202.700 | 0,34% | Opzione Call |
| REDWOOD CAPITAL MANAGEMENT, LLC | $45.740.000 | 200.000 | 0,33% | Azioni |
| DEUTSCHE BANK AG\ | $45.272.766 | 197.957 | 0,33% | Azioni |
| INVESTMENT HOUSE LLC | $44.310.854 | 193.751 | 0,32% | Azioni |
| JANE STREET GROUP, LLC | $43.224.300 | 189.000 | 0,31% | Opzione Put |
| Fiera Capital Corp | $43.130.075 | 188.588 | 0,31% | Azioni |
| Summit Street Capital Management, LLC | $41.630.489 | 182.031 | 0,30% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $41.211.511 | 180.199 | 0,30% | Azioni |
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Mary R. Molina Living Trust, Exempt Mary R. Molina Living Trust, Mary R. Molina Grantor Retained Annuity Trust 609/4, Mary R. Molina Grantor Retained Annuity Trust 609/7, Mary R. Molina Grantor Retained Annuity Trust 1209/3, Mary R. Molina Grantor Retained Annuity Trust 1209/4, Mary R. Molina Grantor Retained Annuity Trust 610/4, Mary R. Molina Grantor Retained Annuity Trust 610/5, Mary R. Molina Grantor Retained Annuity Trust 1210/4, Mary R. Molina Grantor Retained Annuity Trust 811/3, Mary R. Molina Grantor Retained Annuity Trust 812/3, Estate of Mary R. Molina, Dentino Family Trust, Curtis and Rosi Pedersen 2012 Trust, William Dentino, Curtis Pedersen ×3 depositi | 23 Gennaio 2018 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 62 insider · 25 dirigenti · 19 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Roman Kulich | Pres & CEO of Molina of MI | 22 Agosto 2007 S | 5.734 | 0 | 0 | $0 |
| Gerald Landgraf | CEO/Pres of Molina of NM | 01 Luglio 2005 A | · | 0 | 0 | $0 |
| Mark Lowell Keim | Chief Financial Officer | 01 Marzo 2026 A | 83.251 | 0 | 0 | $0 |
| Joseph W White CPA | Former Chief Financial Officer | 06 Giugno 2018 D | 48.390 | 0 | 0 | $0 |
| James Woys | Chief Operating Officer | 30 Giugno 2026 A | 90.178 | 0 | 0 | $0 |
| Terry Bayer | Chief Operating Officer | 02 Febbraio 2018 D | 28.730 | 0 | 0 | $0 |
| Debra Bacon | EVP, Medicaid | 01 Luglio 2026 F | 21.636 | 0 | 0 | $0 |
| Jeff D. Barlow | Chief Legal Officer | 30 Giugno 2026 A | 67.313 | 0 | 1 | $-3.314.983 |
| Marc Russo | EVP, Health Plans | 07 Agosto 2023 S | 37.093 | 0 | 0 | $0 |
| Pamela Sedmak | Executive Vice President | 01 Marzo 2020 F | 8.846 | 0 | 0 | $0 |
| Lisa A Rubino | Senior Vice President | 01 Marzo 2018 F | 25.084 | 0 | 0 | $0 |
| Keith Wilson | Chief Medical Officer | 30 Giugno 2017 A | 29.441 | 0 | 0 | $0 |
| Amir Desai | Chief Information Officer | 16 Agosto 2010 S | 16.782 | 0 | 0 | $0 |
| Mark L Andrews ESQ | Exec. VP, General Counsel | 01 Luglio 2010 F | 51.006 | 0 | 0 | $0 |
| Mary Martha Bernadett MD | Exec. V.P., Research | 05 Dicembre 2008 J | 50.000 | 0 | 0 | $0 |
| Stephen T O'Dell | Regional Vice President | 07 Agosto 2008 F | 16.199 | 0 | 0 | $0 |
| Lillis Ann Koontz | Regional Vice President | 30 Giugno 2008 A | 15.304 | 0 | 0 | $0 |
| George Kirk Olsen | VP, Molina Advantage | 29 Giugno 2007 A | 7.822 | 0 | 0 | $0 |
| Michael M Siegel | Chief Medical Officer | 01 Marzo 2007 A | 5.150 | 0 | 0 | $0 |
| Rick Click | Chief Information Officer | 01 Marzo 2007 A | 8.500 | 0 | 0 | $0 |
| Harvey A Fein | VP, Internal Auditing | 01 Marzo 2007 A | 8.713 | 0 | 0 | $0 |
| Joann Zarza-Garrido | VP, Compliance | 28 Febbraio 2007 S | 4.774 | 0 | 0 | $0 |
| William Bracciodieta | Former Chief Medical Officer | 16 Febbraio 2007 F | 5.000 | 0 | 0 | $0 |
| Sheila Shapiro | Exec. VP, Shared Services | 30 Dicembre 2005 J | 12.564 | 0 | 0 | $0 |
| Jennings Patricia Dinsmore | VP Qual. Op. & Integration | 16 Agosto 2004 S | 0 | 0 | 0 | $0 |
| Stephen H Lockhart | Direttore | 01 Ottobre 2026 A | 4.688 | 0 | 0 | $0 |
| Richard M Schapiro | Direttore | 01 Ottobre 2026 A | 12.615 | 0 | 1 | $-51.058 |
| Richard C Zoretic | Direttore | 01 Ottobre 2026 A | 9.693 | 1 | 0 | $100.128 |
| Leo P Grohowski | Direttore | 01 Ottobre 2026 A | 1.846 | 0 | 0 | $0 |
| Francis S Soistman JR | Direttore | 01 Ottobre 2026 A | 1.211 | 0 | 0 | $0 |
| Dale B Wolf | Direttore | 01 Ottobre 2026 A | 15.937 | 0 | 0 | $0 |
| Steven J Orlando | Direttore | 01 Ottobre 2026 A | 18.271 | 0 | 0 | $0 |
| Ronna Romney | Direttore | 01 Ottobre 2026 A | 18.173 | 0 | 1 | $-74.342 |
| Barbara L Brasier | Direttore | 01 Ottobre 2026 A | 6.122 | 0 | 0 | $0 |
| Daniel Cooperman | Direttore | 01 Aprile 2025 A | 6.383 | 0 | 0 | $0 |
| Garrey Carruthers | Direttore | 01 Aprile 2021 A | 5.265 | 0 | 0 | $0 |
| Charles Z Fedak | Direttore | 01 Aprile 2019 A | 19.092 | 0 | 0 | $0 |
| John C Molina | Direttore | 20 Febbraio 2018 S | 372.930 | 0 | 0 | $0 |
| Frank E Murray MD | Direttore | 01 Ottobre 2017 A | 16.811 | 0 | 0 | $0 |
| Steven James | Direttore | 01 Aprile 2016 A | 15.024 | 0 | 0 | $0 |
| John P Szabo JR | Direttore | 01 Aprile 2015 A | 17.097 | 0 | 0 | $0 |
| Sally K Richardson | Direttore | 03 Maggio 2012 A | 47.537 | 0 | 0 | $0 |
| Wayne B Lowell | Direttore | 10 Maggio 2007 A | 10.011 | 0 | 0 | $0 |
| Ronald Cpa Dba Lossett | Direttore | 10 Febbraio 2004 A | · | 0 | 0 | $0 |
| MARY R MOLINA LIVING TRUST | Proprietario del 10% | 14 Dicembre 2009 J | 2.137.134 | 0 | 0 | $0 |
| MOLINA MARITAL TRUST | Proprietario del 10% | 22 Giugno 2006 S | 2.926.907 | 0 | 0 | $0 |
| Maurice Hebert | · | 14 Maggio 2026 S | 12.815 | 0 | 1 | $-114.930 |
| Joseph M Zubretsky | · | 01 Marzo 2026 A | 99.015 | 0 | 0 | $0 |
| Thomas L Tran | · | 24 Maggio 2021 F | 29.775 | 0 | 0 | $0 |
| Norman Nichols | · | 08 Agosto 2018 S | 47.415 | 0 | 0 | $0 |
| Harold Gooch | · | 30 Giugno 2018 A | 7.063 | 0 | 0 | $0 |
| Mario J Molina MD | · | 11 Dicembre 2017 S | 61.125 | 0 | 0 | $0 |
| James W Howatt | · | 19 Marzo 2010 S | 34.081 | 0 | 0 | $0 |
| Curtis Pedersen | · | 05 Novembre 2009 G | 1.200 | 0 | 0 | $0 |
| Josephine M Molina | · | 06 Agosto 2008 J | 345.701 | 0 | 0 | $0 |
| Janet M Watt | · | 06 Agosto 2008 J | 284.641 | 0 | 0 | $0 |
| Josephine M Battiste | · | 06 Agosto 2008 J | 345.701 | 0 | 0 | $0 |
| Zarina Sparling | · | 21 Febbraio 2008 M | 9.380 | 0 | 0 | $0 |
| Mary R Molina | · | 27 Settembre 2006 J | 0 | 0 | 0 | $0 |
| George S Goldstein PHD | · | 11 Maggio 2006 M | 0 | 0 | 0 | $0 |
| Richard A Helmer MD | · | 30 Giugno 2005 J | 1.908 | 0 | 0 | $0 |
| David W Erickson | · | 02 Dicembre 2004 M | 0 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 74 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| SOVF · Elevation Series Trust | 4,23% | 18.894 NS | 31 Luglio 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 1,71% | 120.017 SH | 02 Ottobre 2026 | Giornaliero |
| RFV · Invesco Exchange-Traded Fund Trust | 1,66% | 29.907 SH | 02 Ottobre 2026 | Giornaliero |
| IHF · iShares Trust | 1,53% | 100.080 SH | 11 Settembre 2026 | Giornaliero |
| VIOV · VANGUARD ADMIRAL FUNDS | 1,28% | 110.553 SH | 19 Agosto 2026 | Giornaliero |
| PIZ · Invesco Exchange-Traded Fund Trust … | 1,17% | 105.488 SH | 02 Ottobre 2026 | Giornaliero |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0,76% | 5.983.000 | 02 Ottobre 2026 | Giornaliero |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,64% | 182.154 SH | 19 Agosto 2026 | Giornaliero |
| FFLV · FIDELITY COVINGTON TRUST | 0,41% | 343 NS | 31 Luglio 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,40% | 6.790 NS | 31 Luglio 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,31% | 7.103 SH | 02 Ottobre 2026 | Giornaliero |
| DFAT · Dimensional ETF Trust | 0,27% | 198.247 NS | 31 Luglio 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,26% | 8.610 NS | 31 Luglio 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,25% | 758.589 SH | 19 Agosto 2026 | Giornaliero |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 22.626 NS | 31 Luglio 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,22% | 765 NS | 31 Luglio 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,20% | 3.918 NS | 31 Luglio 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,18% | 156.577 SH | 19 Agosto 2026 | Giornaliero |
| ESML · iShares Trust | 0,17% | 23.899 SH | 11 Settembre 2026 | Giornaliero |
| IYH · iShares Trust | 0,17% | 30.059 SH | 11 Settembre 2026 | Giornaliero |
| DFSV · Dimensional ETF Trust | 0,16% | 67.624 NS | 31 Luglio 2026 | N-PORT |
| ISCG · iShares Trust | 0,16% | 7.446 SH | 11 Settembre 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,15% | 24.870 NS | 31 Luglio 2026 | N-PORT |
| SMMD · iShares Trust | 0,14% | 27.458 SH | 11 Settembre 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | 0,14% | 1.195.007 SH | 19 Agosto 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,13% | 597.850 SH | 19 Agosto 2026 | Giornaliero |
| IWS · iShares Trust | 0,10% | 77.233 SH | 11 Settembre 2026 | Giornaliero |
| WSML · iShares Trust | 0,10% | 3.305 SH | 11 Settembre 2026 | Giornaliero |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,09% | 4.929 SH | 02 Ottobre 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,09% | 68.863 NS | 31 Luglio 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 3.775 SH | 02 Ottobre 2026 | Giornaliero |
| IWR · iShares Trust | 0,08% | 210.604 SH | 11 Settembre 2026 | Giornaliero |
| PRF · Invesco Exchange-Traded Fund Trust | 0,06% | 35.013 SH | 02 Ottobre 2026 | Giornaliero |
| EMGF · iShares, Inc. | 0,06% | 15.805 SH | 11 Settembre 2026 | Giornaliero |
| DXUV · Dimensional ETF Trust | 0,05% | 1.409 NS | 31 Luglio 2026 | N-PORT |
| EMXC · iShares, Inc. | 0,05% | 162.911 SH | 11 Settembre 2026 | Giornaliero |
| DFSU · Dimensional ETF Trust | 0,04% | 5.157 NS | 31 Luglio 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,03% | 305 NS | 31 Luglio 2026 | N-PORT |
| IUSV · iShares Trust | 0,03% | 45.470 SH | 11 Settembre 2026 | Giornaliero |
| IEMG · iShares, Inc. | 0,03% | 689.771 SH | 11 Settembre 2026 | Giornaliero |
| EEM · iShares, Inc. | 0,03% | 131.827 SH | 11 Settembre 2026 | Giornaliero |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 31.058 SH | 19 Agosto 2026 | Giornaliero |
| IWD · iShares Trust | 0,03% | 114.206 SH | 11 Settembre 2026 | Giornaliero |
| DFUV · Dimensional ETF Trust | 0,03% | 20.443 NS | 31 Luglio 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,03% | 52.472 SH | 11 Settembre 2026 | Giornaliero |
| TILT · FlexShares Trust | 0,02% | 2.686 NS | 31 Luglio 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 1.655.258 SH | 19 Agosto 2026 | Giornaliero |
| VWO · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 868.836 SH | 19 Agosto 2026 | Giornaliero |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 8.548 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 4.354 SH | 19 Agosto 2026 | Giornaliero |
| ESGV · VANGUARD WORLD FUND | 0,02% | 11.634 SH | 19 Agosto 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,02% | 45.023 NS | 31 Luglio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 2.946 NS | 31 Luglio 2026 | N-PORT |
| IXUS · iShares Trust | 0,02% | 126.782 SH | 11 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,01% | 14.718 SH | 11 Settembre 2026 | Giornaliero |
| IWB · iShares Trust | 0,01% | 35.396 SH | 11 Settembre 2026 | Giornaliero |
| IYY · iShares Trust | 0,01% | 2.168 SH | 11 Settembre 2026 | Giornaliero |
| DFUS · Dimensional ETF Trust | 0,01% | 15.184 NS | 31 Luglio 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 67.059 SH | 11 Settembre 2026 | Giornaliero |
| DFAU · Dimensional ETF Trust | 0,01% | 8.285 NS | 31 Luglio 2026 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0,01% | 531.000 SH | 11 Settembre 2026 | Giornaliero |
| VOXP · Advisors Series Trust | 0,01% | 3 NS | 31 Luglio 2026 | N-PORT |
| ACWX · iShares Trust | 0,01% | 16.724 SH | 11 Settembre 2026 | Giornaliero |
| VXUS · VANGUARD STAR FUNDS | 0,01% | 910.737 SH | 19 Agosto 2026 | Giornaliero |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 145.760 SH | 19 Agosto 2026 | Giornaliero |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 89.282 SH | 19 Agosto 2026 | Giornaliero |
| VYMI · VANGUARD WHITEHALL FUNDS | 0,01% | 68.906 SH | 19 Agosto 2026 | Giornaliero |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2.303 SH | 02 Ottobre 2026 | Giornaliero |
| ACWI · iShares Trust | 0,00% | 8.307 SH | 11 Settembre 2026 | Giornaliero |
| IJH · iShares Trust | · | 1.828.162 SH | 11 Settembre 2026 | Giornaliero |
| IJJ · iShares Trust | · | 265.658 SH | 21 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | · | 2.352 SH | 11 Settembre 2026 | Giornaliero |
| ISCV · iShares Trust | · | 6.481 SH | 11 Settembre 2026 | Giornaliero |
| SMMV · iShares Trust | · | 4.872 SH | 01 Settembre 2026 | Giornaliero |
MOH Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
Target Price a 12 Mesi
17 analisti · 2026-09-30Target medio $209.12 +10,3%
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.